Loading insider details...
Latest Form 4 (Oct 30, 2026): Exercise/Conversion of 8,000 SNDX shares, $94.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 30, 2026 | Syndax Pharmaceuticals Inc (SNDX) | Exercise/Conversion | 8,000 | $94.5K |
| Feb 6, 2026 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 48,000 | n/a |
| Aug 18, 2025 | Syndax Pharmaceuticals Inc (SNDX) | Exercise/Conversion | 19,200 | $138.2K |
| Feb 7, 2025 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 50,000 | n/a |
| Feb 9, 2024 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 34,000 | n/a |
| Feb 3, 2023 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 32,000 | n/a |
| Sep 16, 2022 | Syndax Pharmaceuticals Inc (SNDX) | Exercise/Conversion | 66,840 | $422.4K |
| Feb 3, 2022 | Syndax Pharmaceuticals Inc (SNDX) | Grant/Award | 32,000 | n/a |
| Oct 6, 2021 | Syndax Pharmaceuticals Inc (SNDX) | Other (see footnotes) | 463 | n/a |
| Apr 22, 2021 | Syndax Pharmaceuticals Inc (SNDX) | Purchase | 13,967 | $197.1K |